RNA
Avidity Biosciences, Inc. Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$72.72
$-0.21
(-0.29%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $11.23B | EPS (ttm) | $-4.19 | Current Price | $72.72 |
| Enterprise Value | $9.13B | Forward EPS | $-4.92 | Previous Close | $72.93 |
| P/E Ratio | - | ROA | -20.28% | 52W High | $73.06 |
| Forward P/E | -14.78 | ROE | -32.44% | 52W Low | $21.51 |
| PEG Ratio | - | Gross Margin | - | 50 Day Avg | $72.05 |
| P/S Ratio | 538.32 | Operating Margin | -1513.47% | 200 Day Avg | $49.25 |
| P/B Ratio | 5.66 | Profit Margin | - | Volume | 3.92M |
| EV/EBITDA | -14.99 | Current Ratio | 11.57 | Avg Volume | 2.43M |
| EV/Sales | 437.57 | Quick Ratio | 11.13 | Beta | 0.93 |
| Employees | 391.00 | Debt/Equity | 2.65 | Shares Outstanding | 154.48M |
| Sector | Healthcare | Total Debt | $49.97M | Float Shares | 128.51M |
| Industry | Biotechnology | Total Cash | $1.88B | Short Float | 5.62% |
| Optionable | Yes | Cash/Share | $12.45 | Short Ratio | 4.27 |
| Dividend Yield | - | Book Value/Share | $12.85 | % Held by Insiders | 3.72% |
| Target Price | $74.64 | Revenue (TTM) | $20.87M | % Held by Institutions | 97.72% |